15 Jun, 2022

What Does the Future Hold for Liquid Biopsy Technology

Maik Pruess, PhD  Senior Field Applications Scientist What Does the Future Hold for Liquid Biopsy Technology? Liquid biopsy is a fascinating and quickly evolving technology. Since the early 2000s, these tests have become increasingly complex, capable of gathering data on tens of thousands of genes across a patient’s DNA [...]

8 Jun, 2022

Liquid Biopsies: A Technical Dive into Biology and Innovations

Travis J. Yates, PhD  Field Applications Scientist Liquid Biopsies: A Technical Dive into Biology and Innovations If you’ve been following our series thus far, you’ve learned that while new and innovative strategies to combat the progression of malignant disease continue to evolve, the field has an unmet need. The [...]

3 Jun, 2022

How variant-specific shedding may be key for ctDNA test interpretation

Lee McDaniel, MD, MSE Sr. Bioinformatics Scientist How variant-specific shedding may be key for ctDNA test interpretation In a study led by University of Pennsylvania and the Parker Institute for Cancer Immunotherapy, Personalis is a co-author on a poster being presented at the American Society of Clinical Oncology (ASCO) [...]

23 May, 2022

An Introduction to the Personalis Liquid Biopsy Approach

Kedar Hastak, MS, PhD Manager, Field Applications Scientist An Introduction to the Personalis® Liquid Biopsy Approach As oncology technology continues to improve, there is an ever-growing buzz surrounding the topic of liquid biopsies. Just on its own, the concept itself is captivating: instead of having to take a physical sample [...]

11 May, 2022

How Liquid Biopsy Technology is Changing What’s Possible in Cancer Treatment

Erin Newburn, MS, PhD Sr. Director, Field Applications Scientist How Liquid Biopsy Technology is Changing What's Possible in Cancer Treatment There’s no doubt that early detection is essential for good outcomes when dealing with cancer treatment, and this is equally true when detecting disease recurrence. Patients who have already undergone [...]

4 May, 2022

Understanding and Evaluating the Latest Advances in Liquid Biopsy Technology

Dan Norton Associate Director, Product Management Personalis, Inc. Understanding and Evaluating the Latest Advances in Liquid Biopsy Technology Liquid biopsies are a hot topic in oncology, and for good reason. Some tout them as a relatively painless alternative to operations that can be difficult, expensive, and extremely uncomfortable. While others [...]

29 Apr, 2022

Whole-genome sequencing approach for cancer validated by Cambridge study

Dan Norton Associate Director, Product Management Personalis, Inc. Whole-genome sequencing approach for cancer validated by Cambridge study One of the most interesting aspects of precision medicine is that in order to treat each person’s disease individually, we have to understand how the disease looks across a population. In other words, [...]

Go to Top